Search PubMed⌕ Search

Biomedical subjects

M Turina

Publications and source records attributed to M Turina.

At least 73 records · Page 4Linked to original sources
PubMed1999

Transfemoral endografting of thoracic aortic aneurysm under local anesthesia: a simple, safe and fast track procedure.

BACKGROUND: Endovascular aneurysm grafting of the descending thoracic aorta is a minimally invasive catheter technique, which is performed under general anesthesia. We describe a technique allowing to perform transfemoral endovascular repair of thoracic aortic repair under local anesthesia. PATIENTS AND METHODS: In 9 consecutive patients local anesthesia was performed in order to gain an opened femoral artery access for the delivery system, and a percutaneous access to the left brachial artery. A pigtail catheter was then placed through the left brachial artery for the location of the origin of the left subclavian artery and/or the aneurysm and self-expanding endoprosthesis was released under fluoroscopic guidance. For the deployment of the endograft a short period of controlled hypotension with nitroglycerin bolus application was produced. RESULTS: All the aneurysms could be successfully sealed with the intended endovascular technique. There was no vascular access complication or pulmonary or ischemic (cardiac, cerebral or peripheral) complication. In the follow-up period of 6 +/- 3 months one patient needed a redo endovascular procedure because of the development of a severe and symptomatic distal endoleak 6 weeks postoperative. This procedure was again performed under local anesthesia. CONCLUSIONS: From a technical point of view, transfemoral endovascular repair of thoracic aneurysm can be performed under local anesthesia. This is a very simple and fast track procedure which combines a minimally invasive catheter technique and a less invasive anesthetic management.

Adult↗
PubMed1999

Flow measurements through aortocoronary and intraluminal coronary shunts.

AIMS: Temporary insertion of shunts during coronary artery bypass grafting (CABG) on the beating heart may provide the minimal flow required for adequate myocardial protection (40 to 60 ml/min). We investigated the flow as a function of the pressure head over three aortocoronary shunts and one intraluminal coronary shunt. METHODS: The aortocoronary shunts (VS-01590 with bulb size 2, 3 and 4 mm) and the intraluminal shunt (IVS-4030, bulb size 4 mm) were perfused with 47% glycerin solution at 37 degrees C. The preload was raised in 5 mmHg steps from 35 to 80 mmHg. The afterload was set at 12 mmHg. A regression analysis of the flow on the pressure head was performed. RESULTS: For maximal preload the flow through the aortocoronary shunts was 15.9 +/- 1.3, 46.2 +/- 2.2 and 75.4 +/- 3.3 ml/min, for the intraluminal shunt it was 76.1 +/- 3.4 ml/min. To provide a flow of 40 ml/min a preload of 70, 50 and 45 mmHg was necessary for the 3 mm and 4 mm aortocoronary shunt and the intraluminal shunt respectively. For the aortocoronary and the intraluminal shunts the beta-coefficients were 0.27, 0.66, 1.13 and 1.02 ml/(min*mmHg) respectively with all p < 0.0001. CONCLUSIONS: For adequate pressure head the 3 mm and 4 mm aortocoronary shunt and the intraluminal shunt provide myocardial protection. In case of severe proximal coronary stenosis the intraluminal shunt will not guarantee myocardial protection and main benefit reduces to working in a bloodless field. The insertion of shunts is a cheap and simple method to optimize CABG on the beating heart.

Arteriovenous Shunt, Surgical↗
PubMed1999

[Emergency surgery for abdominal aortic aneurysm--could an endovascular methods be considered?].

AIMS: The endovascular repair of abdominal aortic aneurysms (AAA) is a minimally invasive method which can be performed without laparotomy, thoracotomy or cross-clamping. Little is known about the endovascular feasibility in patients with contained ruptures. METHODS: Retrospective study on 31 patients (mean age 70 +/- 6 years, 27 men (87.1%) and 4 (12.9%) women), who were treated for a ruptured aortic aneurysm between January 1996 and July 1998. RESULTS: 17/31 (55%) patients were hemodynamically stable. 14 patients were in severe shock and two died preoperatively. The operative mortality (two just after entering the abdomen) was 17% (5/29 patients) due to irreversible shock. A graft repair was performed in 27 patients. Preoperative CT scan was available in 12/31 (39%) patients. An infrarenal neck was present in all patients (length: 19 +/- 9 mm, internal diameter: 23 +/- 5 mm). The internal diameter of the external iliac artery was 10 +/- 2 mm. Six patients has an additional aneurysm of the common iliac artery, none of them bilaterally. In one patient infrarenal kinking of more than 90 degrees was detected. CONCLUSIONS: In regard to the morphology, endovascular treatment would have been feasible in the majority of the patients where CT was already performed. Moreover, hemodynamic situation would have allowed to assess feasibility with a CT and perform endovascular treatment in most of patients with symptomatic or ruptured AAA. In conclusion, hemodynamically stable patients with symptomatic or leaking AAA should be investigated for endovascular repair.

Age Factors↗
PubMed1999

Composite graft replacement of the aortic root: long-term results, incidence of reoperations.

BACKGROUND: Long-term results after composite graft replacement of the aortic root may depend on the insertion technique. METHODS: 181 consecutive patients (mean age 53 years; 153 men) operated on between 1983 and 1993 were studied. Indications for surgery were annuloaortic ectasia (n=98), acute aortic dissection (n = 46), other indications (n = 12), and various indications after previous aortic valve replacement (n = 25). Mean follow-up was 28 months. The open-button technique was performed in 74 patients (41 %) and the Bentall inclusion technique in 107 patients (59%), with a Cabrol shunt to the right atrium in 16 patients. RESULTS: Overall survival was 75% after 7 years, significantly decreased in acute aortic dissection (p = 0.0019) and without difference between the two surgical techniques (p = 0.3166). Reoperation-free survival was 69% at 7 years and significantly decreased after acute dissection (p = 0.0421 ). Pseudoaneurysm formation only occurred in 3 patients operated with the Bentall technique not including a Cabrol shunt. CONCLUSIONS: Long-term results are satisfactory. In acute aortic dissection survival is decreased and late reoperations more frequent. The open technique is safe in non-dissection and in acute dissection and avoids pseudoaneurysm formation. The Bentall technique combined with Cabrol shunt is indicated if there is a high risk of hemorrhage. Long-term monitoring of the aorta is mandatory in patients with acute dissection and/or Marfan disease.

Acute Disease↗
PubMed1999

Acute hemodynamic effects of alternate and combined site pacing in patients after cardiac surgery.

We hypothesized that pacing at sites other than the right ventricular (RV) apex or at two or more ventricular sites would activate the myocardium more rapidly and improve cardiac function in patients undergoing coronary revascularization or aortic valve replacement. Epicardial electrodes were placed on the right atrium (A), RV paraseptal area close to the RV apex (B), RV outflow tract (C), LV apex (D), in patients undergoing bypass surgery. At constant rate and AV delay, we measured CO during A pacing, DVI pacing at B, C, D, and various combinations of sites in random order in ten patients with EF > 50% and 27 patients with EF < or = 50%. When pacing at two sites, we made one electrode a cathode and one an anode and noted two distinct thresholds by careful observation of the 12-lead ECG. There were no significant differences in CO, systemic vascular resistance, systolic, or mean arterial pressure. Significant differences were noted in QRS duration, which increased progressively going from AAI to 3-site, 2-site, and single site pacing (P < 0.05 each comparison). Thus: (1) QRS duration correlated inversely with the number of ventricular sites paced; (2) despite this, CO did not improve irrespective of baseline EF; (3) multisite pacing produced multiple distinct thresholds which appeared to be related to the number of sites paced, and (4) unique ECG patterns confirmed multisite pacing.

Aortic Valve↗
PubMed1999

Pregnancy after atrial repair for transposition of the great arteries.

OBJECTIVE: To investigate the risk of pregnancy in patients with transposition of the great arteries (TGA) who have undergone atrial repair. DESIGN: Retrospective analysis (1962-94) of 342 TGA patients who underwent atrial repair. Of 231 known late survivors, 48 were women over 18 years old who were interviewed about possible reproductive plans and previous pregnancies. As a control, comparison was made with data of 57 500 women (mean age 26 years) obtained from the Swiss Statistical Bank in Bern. RESULTS: Mean follow up was 13.7 years; 66% remained asymptomatic, 29% had mild to moderate cardiac symptoms, and 5% suffered from severe cardiac symptoms (New York Heart Association grade III-IV). Thirty six of the 48 women wished to bear children and, to date, there have been 10 live births, two spontaneous first trimester abortions, and one induced abortion at 16 weeks. During pregnancy there was one case of cardiac deterioration and two cases of pneumonia. There was no evidence of congenital heart disease in the children. CONCLUSIONS: In this relatively small series the completion of pregnancy in women with TGA who had undergone atrial repair and who had normal functional cardiac status was uncomplicated

Abortion, Spontaneous↗
PubMed1999

Optimized performance of the Abiomed BVS 5000: adjustment of the pump height based on Doppler control of the flow pattern.

The Abiomed BVS 5000 is an automatic volume-driven paracorporeal pulsatile assist device providing left, right or biventricular support. The paracorporeal position allows optical adjustment of filling volumes of the device, which determines the output of the system. A procedure to adjust for maximal stable flow has not yet been established. In vitro measurements have been performed to assess the flow and pressure characteristics of the Abiomed BVS 5000 by raising the preload in 5 mmHg steps before running the system. Doppler probes were placed at the inflow and outflow lines of the pump. After setting the afterload at 80 mmHg the assist device was started. Two measurements were performed to find optimal flow (based on Doppler control and optical adjustment). (1) By Doppler control a stable flow pattern was found at a preload of 25 mmHg with a mean atrial pressure of 5 mmHg and a mean flow of 5.3 +/- 0.7 l/min (mean +/- standard deviation) at the inflow and outflow sites (the console flow was 4.8 +/- 0.4 l/min with a frequency of 61.8 +/- 2.0 l/min). (2) Optical adjustment of the pump height gave rise to a preload of 35 mmHg where we recorded a maximal atrial pressure of 107 +/- 5.8 mmHg, a maximal retrograde flow of -4.3 +/- 1.2 l/min at the inflow and -1.2 +/- 0.4 l/min at the outflow site. The mean flow at the inflow and outflow sites was 5.1 +/- 0.5 l/min (the console flow was 4.6 +/- 0.3 l/min with a frequency of 59.6 +/- 2.6 Hz). At an initial afterload of 60 and 40 mmHg the system showed the same qualitative behaviour, but the results were less accurate. Optical adjustment of the pump height may result in an atrioventricular valve insufficiency with undetected retrograde flow and high atrial pressures. We conclude that a Doppler flow probe must be placed at the inflow site to guarantee maximal stable flow.

Equipment Design↗
PubMed1999

Hemodynamic properties of the hemopump HP14.

BACKGROUND: The Hemopump HP14 is a catheter-mounted, transvalvular, left ventricular assist device intended for femoral percutaneous insertion. The pump was developed for patients with postoperative or postinterventional low cardiac output and for CABG surgery on the beating heart. Little is known about the effect of afterload and hematocrit on the pump performance. METHODS: The influence of hematocrit and afterload on the pump flow was tested using an in vitro model filled with heparinized bovine blood. Regression analysis of the pump flow with respect to three hematocrit values (20%, 30%, 40%) and ten afterload levels (30 mmHg-120 mmHg in 10 mmHg increments) was performed for all pump speed levels (n = 7). RESULTS: At all pump speed levels reduction of afterload and hematocrit were significant predictors for increasing pump flow (p<0.001). For hematocrit values between 40% and 20% and highest pump speed, mean pump flow at lowest afterload ranged between 2.34 and 2.53 L/min; and at highest afterload between 1.31 and 1.53 L/min. For speed level 1, afterload of 120 mmHg and hematocrit of 40% there was a maximal retrograde flow of 230+/-35 ml/min. CONCLUSIONS: Pump performance is significantly improved by both afterload and hematocrit reduction. In the weaning phase and during the removal of the device, the pump should run at a speed level of at least three to prevent retrograde flow in the pump. Estimates for pump flow in vivo can be extrapolated from our diagrams. Our results show that the Hemopump HP14 is a valuable alternative to intra-aortic balloon counterpulsation.

Animals↗
PubMed1998

Valve replacement in chronic aortic regurgitation. True predictors of survival after extended follow-up.

BACKGROUND: The influence of preoperative clinic, hemodynamic, and surgical procedures on extended long-term prognosis after valve replacement for chronic aortic regurgitation is still unclear. METHODS AND RESULTS: One hundred ninety-two patients (mean age, 44 years) who underwent valve replacement for chronic aortic regurgitation between 1970 and 1983 were followed for 13 to 26 years (mean follow-up, 13.8 years; surviving patients, 18.7 years). Perioperative mortality was 2.6%; survival rates after 10 and 20 years were 76% and 55%; 65 of 80 deaths were cardiac; 21% of patients were free of cardiac complications after 20 years; and 83 of 100 long-term survivors were in NYHA classes I and II. In a univariate analysis, age at operation (P < 0.0001), higher preoperative NYHA class (P < 0.0001), lower left ventricular (LV) ejection fraction (P = 0.0001), higher end-systolic volume (P = 0.0007), history of endocarditis (P = 0.0004), and additional surgical intervention besides valve replacement (P = 0.004) were the main predictors of late survival. In a multivariate stepwise Cox analysis, age (P = 0.0004), high LV end-systolic volume (P = 0.0004), higher NYHA class (P = 0.01), and previous endocarditis (P = 0.006) were independent predictors. CONCLUSIONS: In chronic aortic regurgitation, symptoms and LV systolic function are the main predictors for extended long-term outcome after valve replacement. Low operative mortality and good extended survival make valve replacement mandatory in mildly or asymptomatic patients when LV systolic function decreases and considerable enlargement of systolic dimensions occur.

Adolescent↗
PubMed1998

Prognosis of medically treated patients referred for cardiac transplantation.

OBJECTIVES: To assess prognosis and factors influencing survival of transplant candidates in whom continued medial therapy was recommended in comparison to that of immediately listed patients. METHODS: Retrospective analysis of clinical, echocardiographic and hemodynamic data as related to survival or listing for transplantation of medically treated transplant candidates. PATIENTS: 160 patients considered 'too well' for cardiac transplantation and 133 patients immediately listed for transplantation. RESULTS: Forty-one of the medically treated patients deteriorated clinically and were listed after 10.7+/-12.3 months after initial evaluation. Mid-term prognosis (2 years) of patients never listed was comparable to that of immediately listed patients (74% vs. 70%) but long-term prognosis (5 years) was worse (41% vs. 54%, p<0.001). Cardiothoracic ratio and pulmonary capillary wedge pressure were independent predictors of survival (multivariate analysis) in patients whose NYHA class and physical working capacity improved and cardiothoracic ratio decreased significantly after adjustment of medical therapy. CONCLUSIONS: Mid-term prognosis of selected patients considered 'too well' for transplantation is comparable to patients immediately listed. Lower left ventricular filling pressures, smaller hearts on chest X-ray on initial evaluation, and improvement of symptoms during follow up may identify a subgroup of patients who do well on optimized therapy.

Actuarial Analysis↗
PubMed1998

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.

BACKGROUND: Graft coronary artery disease (CAD) is an increasingly important problem during long-term survival after heart transplantation, but the importance of cellular rejection, in particular late after transplantation, remains undetermined. METHODS AND RESULTS: We analyzed 492 coronary angiographies (967+/-705 days after transplantation; range, 49 days to 9.4 years) and 5201 endomyocardial biopsies (518+/-648 days after transplantation) from 156 patients (age, 47+/-11 years). Patients with angiographically detectable graft CAD had significantly more episodes of rejection requiring augmentation of immunosuppressive therapy (i.e., International Society of Heart and Lung Transplantation score > or = 3A) than those without graft CAD during the first (3.7+/-2.6 vs. 2.2+/-2.0, P<0.001) as well as subsequent years after transplantation (1.2+/-1.9 vs. 0.4+/-0.9, P<0.01). Multivariate logistic regression analysis including established risk factors for CAD, ischemic time, gender and age of donors and recipients, number of mismatches, cytomegalovirus infection, and drug therapy showed that the number of rejections during the first [odds ratio (OR)=1.39, P<0.005] as well as subsequent years (OR=1.49, P<0.05), previous cytomegalovirus infection (OR=3.21, P<0.05), donor age >40 years (OR=2.97, P<0.05), and current or former smoker status (OR=2.76, P<0.05) were independent predictors of graft CAD. In patients without angiographically detectable graft CAD 1 year after transplantation, the number of rejections after the first year was even more strongly related to graft coronary artery disease than in the total patient population, underlining the importance of late cellular rejection (OR=1.74, P<0.005). CONCLUSION: Rejection requiring augmentation of immunosuppression early and late after transplantation is an independent risk factor for the development of angiographically detectable graft CAD. Hence, the search for and treatment of moderate or severe rejection seems to be prudent even late after transplantation.

Adolescent↗
PubMed1998

Nucleotide sequence and infectivity of a full-length cDNA clone of panicum mosaic virus.

The sequence of an infectious cDNA clone of panicum mosaic virus (PMV) showed that the single-stranded RNA genome is 4326 nucleotides (nt) and a single highly abundant subgenomic (sg) RNA of 1475 nt was synthesized during PMV infection of pearl millet plants and protoplasts. Computer comparisons revealed strong similarities between the predicted amino acid sequences of the p48 and p112 open reading frames (ORFs) and replicase proteins of members of the Tombusviridae. The sgRNA has the potential to encode five proteins. Three small ORFs, p8, p8-FS, and/or p6.6 have similarity to ORFs of carmo-, necro-, and machlomoviruses thought to be involved in virus spread in plants. The sgRNA also has the potential to encode a 26-kDa capsid protein and a 15-kDa nested gene (p15) of unknown function. PMV transcripts also supported replication and movement of SPMV, the satellite virus. Genome organization, physicochemical properties, and biological features indicate that PMV is a member of the Tombusviridae family. However, PMV differs sufficiently from previously described members to warrant its placement in a new genus provisionally designated Panicovirus.

Amino Acid Sequence↗
PubMed1998

Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.

BACKGROUND: Pharmacokinetics and tissue concentrations of amiodarone may vary considerably in end-stage heart failure, but may be crucial for treatment efficiency and antiarrhythmic drug therapy. OBJECTIVE: This study was undertaken to determine plasma amiodarone and desethylamiodarone concentrations and to determine whether they correlate with myocardial concentrations in explanted hearts from patients with end-stage heart failure. PATIENTS AND METHODS: Eight patients with idiopathic dilated cardiomyopathy and normal coronary arteries were included in the present study. Myocardial tissue samples (seven sites) and epicardial fat were taken from each explanted heart, and drug concentrations of amiodarone and desethylamiodarone were determined. In addition, plasma drug levels were measured and compared with the myocardial amiodarone/desethylamiodarone concentrations. RESULTS: The mean cumulative amiodarone dose was 91 g and the mean plasma concentrations of amiodarone and desethylamiodarone were 0.68 and 0.84 microg.ml(-1), respectively. The tissue concentrations of amiodarone amounted to 13.2 and 28.3 microg.g(-1), respectively, in the atria and to 13.0 and 40.8 microg.g(-1), respectively, in the ventricles. The distribution of the drug and its metabolite were similar in the right and left ventricles. There was a good correlation between myocardial concentration of amiodarone and desethylamiodarone and the cumulative ingested dose of amiodarone. Tissue drug concentrations correlated only poorly with plasma amiodarone or desethylamiodarone levels. The highest drug levels were measured in the epicardial fat tissue, where the ratio of amiodarone 105 microg.g(-1) to desethylamiodarone 32 microg.g(-1) was reversed (3.3 compared with 0.29 in the ventricles). Thus, amiodarone concentrations in epicardial fat were approximately 10 times higher than myocardial and 150 times higher than plasma levels. CONCLUSIONS: Our data confirm the slow equilibrium of amiodarone and desethylamiodarone concentrations between plasma and myocardium. Myocardial tissue concentrations of desethylamiodarone and, to a lesser degree, amiodarone correlate with the cumulative ingested dose of amiodarone. Monitoring of the total cumulative dose may be more relevant clinically than monitoring plasma levels. These results support the clinical practice of reducing the maintenance dose of amiodarone in patients who are on long-term treatment.

Amiodarone↗
PubMed1998

Tissue engineering: a new approach in cardiovascular surgery: Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh.

OBJECTIVE: In tissue engineering the material properties of synthetic compounds are chosen to enable delivery of dissociated cells onto a scaffold in a manner that will result in in vitro formation of a new functional tissue. The seeding of human fibroblasts followed by human endothelial cells on resorbable mesh is a precondition of a successful creation of human tissues such as vessels or cardiac valves. METHODS: Polymeric scaffolds (n = 18) composed of polyglycolic acid (PGA) with a fiber diameter of 12-15 microm and a polymer density of 70 mg/ml were used as square sheets of 1 x 1 x 0.3 cm. Fibroblasts (passage 7) harvested from human foreskin were seeded (3.4 x 10(6)) and cultured over a 3 week period on a PGA-mesh, followed by seeding of endothelial cells (passage 5, 2.8 x 10(6)) harvested from human ascending aorta. Thereafter the new tissue was stained for HE, van Gieson, Trichrom Masson, Factor VIII and CD 34 and proved by scanning electron microscopy. RESULTS: Microscopic examination of the seeded mesh demonstrated that the human fibroblasts were attached to the polymeric fibers and had begun to spread out and divide. The scanning electron microscopic examination demonstrated a homogeneous scaffold resembling a solid sheet of tissue. The seeded endothelial cells formed a monolayer on the fibroblasts and no endothelial cell invasion or new formation of capillaris could be detected. CONCLUSIONS: These results are a first step to demonstrate that seeding of human fibroblasts and endothelial cells on PGA-mesh might be a feasible model to construct human tissues such as vessels or cardiac valves.

Aorta↗
PubMed1998

Composite graft replacement of the aortic root in acute dissection.

OBJECTIVE: In acute type A dissection the indication for composite graft replacement of the aortic root and the optimal implantation technique are a matter of debate. In this study early and late results of root replacement in acute dissection are determined and compared with supracoronary graft replacement. Two implantation techniques (open vs. inclusion) are evaluated. METHODS: Between 1985 and 1995, 207 consecutive patients (mean age 58 +/- 12 years, 78% men) were operated for acute type A dissection of the aorta. Root replacement in 50 patients (inclusion technique in 34/50 patients with Cabrol shunt in 15/34 patients, open technique in 16/50 patients) was compared with more conservative procedures in 157 patients: supracoronary graft replacement in 143 patients (with aortic valve replacement in 23 patients) and local repair without graft interposition in 14 patients. Preoperative risk factors, like hemodynamic instability, renal failure, neurologic disorder and coronary artery disease did not differ in the two treatment groups. RESULTS: Early results, survival and reoperation-free survival after 5 years were insignificantly better after root replacement: mortality 10/50 (20%) vs. 38/157 (24%) P = n.s.; hemorrhage 10/50 (20%) vs. 39/157 (25%) P = n.s.; stroke 5/50 (10%) vs. 27/157 (17%) P = n.s.; survival 70 +/- 7% vs. 63 +/- 4%, reoperation free survival 92 +/- 6% vs. 78 +/- 5% P = 0.0815). For the open technique, early mortality was 18.8 vs. 20.6%, P = n.s. and reoperation free survival at 5 years was 80.7 vs. 65.2%, P = n.s. Perioperative complications did not differ in the two technical groups and a single pseudoaneurysm occurred in the Bentall group. CONCLUSION: In acute dissection composite graft replacement of the aortic root can be carried out with good early and late results not inferior to more conservative procedures. The open technique is the implantation method of choice and the modified Bentall technique is indicated in situations with increased risk of bleeding.

Acute Disease↗
PubMed1998

Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules.

OBJECTIVE: Cardiac surgery with cardiopulmonary bypass induces ischemia to the heart, hypoxemia to various tissues and release of endotoxins. The endothelial cell may suffer from hypoxia and trigger cascades of adverse reactions by activation of neutrophils through adhesion molecules. The authors measured expression of intercellular adhesion molecule-1 (ICAM-1), during hypoxia and normoxia and hypothesized that salicylate, which inhibits the nuclear factor-kappaB (NFkappaB), an hypoxia-dependent transmission factor, could reduce this expression. METHODS: Human umbilical vein endothelial cells were cultured and exposed to normoxia and hypoxia in the presence of lipopolysaccharide (LPS). The endothelial cells were thereafter treated with salicylate or indomethacin under the same conditions. The surface expression of ICAM-1 was measured by whole cell enzyme-linked immunosorbent assay (ELISA) and the NFkappaB expression by Western blotting. RESULTS: In the presence of LPS and under hypoxic conditions, the endothelial cells produced a 300 +/- 41% increased expression of ICAM-1 compared with normoxia. The addition of salicylate (0.02-20 mM) completely inhibited the enhanced expression of ICAM-1, the addition of indomethacin at equivalent concentrations did not reduce ICAM-1 expression under either condition. CONCLUSION: ICAM-1 expression is greatly enhanced by the hypoxic endothelial cell in the presence of circulating endotoxin. Pre-treatment with salicylate completely abolishes the enhanced expression. The study suggests that salicylate administered before cardiopulmonary bypass might protect the heart against ischemic/reperfusion injuries and reduce the load of the overall inflammatory reaction.

Blotting, Western↗